Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Scopus BioPharma Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Scopus BioPharma Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Greenspan Ira Scott | Executive Committee Chairman | 14,640Indirect | Nov 26, 2021 | 0 |
| Lamstein Joshua R | Chairman | 119,997 | Nov 26, 2021 | 0 |
| Hopper Paul | Director | – | Nov 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2021 (view filing) | Jul 23 | 4 days | Lamstein Joshua RChairman | PPurchaseCommon Stock, par value $0.001 | +1.50K | $4.71 | +$7.07K | +1.3%118.8K after | |
| Jul 27, 2021 (view filing) | Jul 23-26 | 4 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +2.10K | $4.77 | +$10.0K | +27.1%9.85K after | 2 lots |
| Jul 27, 2021 (view filing) | Jul 26-27 | 1 day | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +600 | $4.69 | +$2.81K | +0.7%81.4K after | 2 lots |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +2.00K | $4.20 | +$8.40K | +20.3%11.8K after | 2 lots |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +2.00K | $4.04 | +$8.08K | +16.9%13.8K after | |
| Aug 23, 2021 (view filing) | Aug 20 | 3 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +400 | $4.23 | +$1.69K | +0.5%81.8K after | |
| Aug 23, 2021 (view filing) | Aug 19 | 4 days | Lamstein Joshua RChairman | PPurchaseCommon Stock, par value $0.001 | +800 | $4.04 | +$3.23K | +0.7%119.6K after | |
| Aug 25, 2021 (view filing) | Aug 23-24 | 2 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +550 | $4.43 | +$2.44K | +0.7%82.3K after | 2 lots |
| Aug 27, 2021 (view filing) | Aug 26-27 | 1 day | Lamstein Joshua RChairman | PPurchaseCommon Stock, par value $0.001 | +400 | $4.95 | +$1.98K | +0.3%120.0K after | 2 lots |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +110 | $4.92 | +$541.2 | +0.1%82.5K after | |
| Aug 30, 2021 (view filing) | Aug 27 | 3 days | Greenspan Ira ScottExecutive Committee Chairman | PPurchaseCommon Stock, par value $0.001 | +790 | $4.98 | +$3.93K | +5.7%14.6K after |